학술논문
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Document Type
Article
Author
Kiladjian, J.-J.; Marin, F.F.; Al-Ali, H.K.; Alvarez-Larrán, A.; Beggiato, E.; Bieniaszewska, M.; Breccia, M.; Buxhofer-Ausch, V.; Cerna, O.; Crisan, A.-M.; Danaila, C.D.; De Stefano, V.; Döhner, K.; Empson, V.; Krejcy, K.; Schlager, S.; Unger, M.; Klade, C.; Gora-Tybor, J.; Griesshammer, M.; Grosicki, S.; Guglielmelli, P.; García-Gutierrez, V.; Heidel, F.H.; Illés, A.; Tomuleasa, C.; James, C.; Koschmieder, S.; Krauth, M.-T.; Lazaroiu, M.-C.; Mayer, J.; Nagy, Z.G.; Nicolini, F.-E.; Palandri, F.; Pappa, V.; Reiter, A.J.; Sacha, T.; Schmidt, S.; Terpos, E.; Wölfler, A.; Cirici, B.X.
Source
In: Annals of Hematology . (Annals of Hematology, July 2024, 103(7):2299-2310)
Subject
Language
English
ISSN
14320584
09395555
09395555